Protein glycosylation in disease: New insights into the congenital muscular dystrophies

Trends in Pharmacological Sciences

Volumn 24, Issue 4, 2003, Pages 178-183

  Martin Rendon, Enca ^a   Blake, Derek J ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; ALPHA DYSTROGLYCAN; BETA DYSTROGLYCAN; BIGLYCAN; DYSTROGLYCAN; FUKUTIN; GENE PRODUCT; GLYCOSYLTRANSFERASE; LAMININ; NEUREXIN; PERLECAN; UNCLASSIFIED DRUG;

CELL MIGRATION; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE EYE BRAIN DISEASE; MUSCULAR DYSTROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MOTIF; PROTEIN PROCESSING; REVIEW; WALKER WARBURG SYNDROME;

EID: 0037388120     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00050-6     Document Type: Review

References (67)

1. Paulson J.C. Glycoproteins: what are the sugar chains for? Trends Biochem. Sci. 14:1989;272-276.
2. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 3:1993;97-130.
3. Marek K.W., et al. A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality. Glycobiology. 9:1999;1263-1271.
4. Shafi R., et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5735-5739.
5. Chui D., et al. Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. Cell. 90:1997;157-167.
6. Blair S.S. Notch signaling: Fringe really is a glycosyltransferase. Curr. Biol. 10:2000;R608-R612.
7. Fortini M.E. Fringe benefits to carbohydrates. Nature. 406:2000;357-358.
8. Herman T., Horvitz H.R. Three proteins involved in Caenorhabditis elegans vulval invagination are similar to components of a glycosylation pathway. Proc. Natl. Acad. Sci. U. S. A. 96:1999;974-979.
9. Burda P., Aebi M. The dolichol pathway of N-linked glycosylation. Biochim. Biophys. Acta. 1426:1999;239-257.
10. Knauer R., Lehle L. The oligosaccharyltransferase complex from yeast. Biochim. Biophys. Acta. 1426:1999;259-273.
11. Van den Steen P., et al. Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 33:1998;151-208.
12. Jaeken J., Matthijs G. Congenital disorders of glycosylation. Annu. Rev. Genomics Hum. Genet. 2:2001;129-151.
13. Freeze H.H. Update and perspectives on congenital disorders of glycosylation. Glycobiology. 11:2001;129R-143R.
14. Mercuri E., Muntoni F. Congenital muscular dystrophies. Emery A.E.H. The Muscular Dystrophies. 2001;10-38 Oxford University Press.
15. Blake D.J., Kroger S. The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle? Trends Neurosci. 23:2000;92-99.
16. Ross M.E., Walsh C.A. Human brain malformations and their lessons for neuronal migration. Annu. Rev. Neurosci. 24:2001;1041-1070.
17. Winder S.J. The complexities of dystroglycan. Trends Biochem. Sci. 26:2001;118-124.
18. Blake D.J., et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82:2002;291-329.
19. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:1993;809-823.
20. Campanelli J.T., et al. A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell. 77:1994;663-674.
21. Gee S.H., et al. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell. 77:1994;675-686.
22. Talts J.F., et al. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J. 18:1999;863-870.
23. Sugita S., et al. A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 154:2001;435-445.
24. Hayashi Y.K., et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology. 57:2001;115-121.
25. Brockington M., et al. Mutations in the fukutin-related protein gene (FKRP) identify limb-girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10:2001;2851-2859.
26. Brockington M., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 69:2001;1198-1209.
27. Kano H., et al. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem. Biophys. Res. Commun. 291:2002;1283-1286.
28. Beltran-Valero De Bernabe D., et al. Mutations in the O-Mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg Syndrome. Am. J. Hum. Genet. 7:2002;1033-1043.
29. Grewal P.K., et al. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat. Genet. 28:2001;151-154.
30. Kobayashi K., et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 394:1998;388-392.
31. Kondo-Iida E., et al. Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum. Mol. Genet. 8:1999;2303-2309.
32. Aravind L., Koonin E.V. The fukutin protein family-predicted enzymes modifying cell-surface molecules. Curr. Biol. 9:1999;R836-R837.
33. Breton C., Imberty A. Structure/function studies of glycosyltransferases. Curr. Opin. Struct. Biol. 9:1999;563-571.
34. Tarbouriech N., et al. Three-dimensional structures of the Mn and Mg dTDP complexes of the family GT-2 glycosyltransferase SpsA: a comparison with related NDP-sugar glycosyltransferases. J. Mol. Biol. 314:2001;655-661.
35. Wiggins C.A., Munro S. Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. Proc. Natl. Acad. Sci. U. S. A. 95:1998;7945-7950.
36. Esapa C.T., et al. Functional requirements for fukutin-related protein in the Golgi apparatus. Hum. Mol. Genet. 11:2002;3319-3331.
37. Topaloglu, H. et al. FKRP gene mutations cause congenital muscular dystrophy 1C, mental retardation and cerebellar cysts. Neurology (in press).
38. Seto N.O., et al. Donor substrate specificity of recombinant human blood group A, B and hybrid A/B glycosyltransferases expressed in Escherichia coli. Eur. J. Biochem. 259:1999;770-775.
39. Cormand B., et al. Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. Am. J. Hum. Genet. 64:1999;126-135.
40. Yoshida A., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell. 1:2001;717-724.
41. Jurado L.A., et al. Identification of a human homolog of the Drosophila rotated abdomen gene (POMT1) encoding a putative protein O-mannosyl-transferase, and assignment to human chromosome 9q34.1. Genomics. 58:1999;171-180.
42. Gentzsch M., Tanner W. The PMT gene family: protein O-glycosylation in Saccharomyces cerevisiae is vital. EMBO J. 15:1996;5752-5759.
43. Martin-Blanco E., Garcia-Bellido A. Mutations in the rotated abdomen locus affect muscle development and reveal an intrinsic asymmetry in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6048-6052.
44. Lane P.W., et al. Myodystrophy, a new myopathy on chromosome 8 of the mouse. J. Hered. 67:1976;135-138.
45. Peyrard M., et al. The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc. Natl. Acad. Sci. U. S. A. 96:1999;598-603.
46. Blake D.J., et al. Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactions. Trends Biochem. Sci. 20:1995;133-135.
47. Holzfeind P.J., et al. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum. Mol. Genet. 11:2002;2673-2687.
48. Michele D.E., et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 418:2002;417-422.
49. Helbling-Leclerc A., et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet. 11:1995;216-218.
50. Moore S.A., et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 418:2002;422-425.
51. Nakano I., et al. Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetus. Acta Neuropathol. (Berl.). 91:1996;313-321.
52. Chiasson J.L., et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 359:2002;2072-2077.
53. Panneerselvam K., Freeze H.H. Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. J. Clin. Invest. 97:1996;1478-1487.
54. Korner C., et al. Carbohydrate-deficient glycoprotein syndrome type 1: correction of the glycosylation defect by deprivation of glucose or supplementation of mannose. Glycoconj. J. 15:1998;499-505.
55. Scott J., et al. Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin. Neuromuscul. Disord. 12:2002;S23-S29.
56. Dickson G., et al. Recombinant micro-genes and dystrophin viral vectors. Neuromuscul. Disord. 12:2002;S40-S44.
57. Jankowski R.J., et al. Muscle-derived stem cells. Gene Ther. 9:2002;642-647.
58. Lee J.Y., et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J. Cell Biol. 150:2000;1085-1100.
59. Gussoni E., et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401:1999;390-394.
60. Nguyen H.H., et al. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5616-5621.
61. Cabral C.M., et al. Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem. Sci. 26:2001;619-624.
62. Ponting C.P. Novel repeats in ryanodine and IP3 receptors and protein O-mannosyltransferases. Trends Biochem. Sci. 25:2000;48-50.
63. Chiba A., et al. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J. Biol. Chem. 272:1997;2156-2162.
64. Sasaki T., et al. Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan. Biochim. Biophys. Acta. 1425:1998;599-606.
65. Peters V., et al. Congenital disorder of glycosylation IId (CDG-IId)-a new entity: clinical presentation with Dandy-Walker malformation and myopathy. Neuropediatrics. 33:2002;27-32.
66. Hansske B., et al. Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J. Clin. Invest. 109:2002;725-733.
67. Paulson J.C., Colley K.J. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J. Biol. Chem. 264:1989;17615-17618.